Correlation Between Purple Biotech and Pluristem

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Purple Biotech and Pluristem at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Purple Biotech and Pluristem into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Purple Biotech and Pluristem, you can compare the effects of market volatilities on Purple Biotech and Pluristem and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Purple Biotech with a short position of Pluristem. Check out your portfolio center. Please also check ongoing floating volatility patterns of Purple Biotech and Pluristem.

Diversification Opportunities for Purple Biotech and Pluristem

0.46
  Correlation Coefficient

Very weak diversification

The 3 months correlation between Purple and Pluristem is 0.46. Overlapping area represents the amount of risk that can be diversified away by holding Purple Biotech and Pluristem in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Pluristem and Purple Biotech is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Purple Biotech are associated (or correlated) with Pluristem. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Pluristem has no effect on the direction of Purple Biotech i.e., Purple Biotech and Pluristem go up and down completely randomly.

Pair Corralation between Purple Biotech and Pluristem

Assuming the 90 days trading horizon Purple Biotech is expected to under-perform the Pluristem. In addition to that, Purple Biotech is 1.02 times more volatile than Pluristem. It trades about -0.54 of its total potential returns per unit of risk. Pluristem is currently generating about 0.18 per unit of volatility. If you would invest  161,100  in Pluristem on August 27, 2024 and sell it today you would earn a total of  25,000  from holding Pluristem or generate 15.52% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

Purple Biotech  vs.  Pluristem

 Performance 
       Timeline  
Purple Biotech 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Purple Biotech has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's basic indicators remain somewhat strong which may send shares a bit higher in December 2024. The current disturbance may also be a sign of long term up-swing for the company investors.
Pluristem 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Pluristem has generated negative risk-adjusted returns adding no value to investors with long positions. Despite somewhat strong basic indicators, Pluristem is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.

Purple Biotech and Pluristem Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Purple Biotech and Pluristem

The main advantage of trading using opposite Purple Biotech and Pluristem positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Purple Biotech position performs unexpectedly, Pluristem can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Pluristem will offset losses from the drop in Pluristem's long position.
The idea behind Purple Biotech and Pluristem pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Fundamental Analysis module to view fundamental data based on most recent published financial statements.

Other Complementary Tools

ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments
Piotroski F Score
Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
FinTech Suite
Use AI to screen and filter profitable investment opportunities
Bonds Directory
Find actively traded corporate debentures issued by US companies